Krajina: Spojené kráľovstvo
Jazyk: angličtina
Zdroj: VMD (Veterinary Medicines Directorate)
Detomidine Hydrochloride
Orion Corporation
QN05CM90
Detomidine Hydrochloride
Solution for injection
POM-V - Prescription Only Medicine – Veterinarian
Horses
Neurological Agent sedative
Authorized
1985-02-13
Revised: June 2020 AN: 02164/2019 Page 1 of 7 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT DOMOSEDAN 10 mg/ml Solution for Injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION ACTIVE INGREDIENT: Detomidine hydrochloride 10 mg/ml EXCIPIENTS: Methyl parahydroxybenzoate (E 218) 1 mg/ml For the full list of excipients, see Section 6.1. 3. PHARMACEUTICAL FORM Solution for Injection Clear, colourless solution 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Horses. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES A sedative with analgesic properties used to facilitate handling of horses for examination, minor surgical interventions and other manipulations._ It can be _ _used with or without butorphanol._ The product is also indicated for use with ketamine for short duration general anaesthesia to carry out surgical procedures such as castration. 4.3 CONTRAINDICATIONS 1. Do not use in conjunction with sympathomimetic amines or with intravenous potentiated sulphonamides. 2. Do not administer simultaneously with ketamine in the same syringe (see sections 4.8 and 4.9). _3._ _Do not use the butorphanol combination in horses suffering from colic._ 4. Do not use in seriously ill animals with heart failure or impaired liver or kidney function. Revised: June 2020 AN: 02164/2019 Page 2 of 7 5. Do not use in case of hypersensitivity to the active substance or to any of the excipients. 6. Do not administer to horses in the last month of pregnancy 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None 4.5 SPECIAL PRECAUTIONS FOR USE i. Special precautions for use in animals The product should not be used in horses with pre-existing AV blocks, with severe cardiac insufficiency, respiratory disease or chronic renal failure. Careful consideration should be given prior to administration to animals in shock and to animals with liver or kidney disease. Intravenous administration should be slow. It is recommended that feed should be withheld for at least 12 hours prior to anaesthesia. The horse should not be Prečítajte si celý dokument